Experts In The News
![Associated Press](/sites/default/files/styles/100_width_25_height/public/news_source/logo/associated-press.png?itok=bN3ZhVzB)
At $1.4 billion, the Powerball jackpot on the line Saturday night is the world’s fifth-largest lottery prize, due to higher interest rates, long odds, fewer ticket sales per drawing and, of course, luck.
![Las Vegas Review Journal](/sites/default/files/styles/100_width_25_height/public/news_source/logo/las-vegas-review-journal.jpg?itok=IX9YBkgU)
What happened to the under-$10, all-you-can-eat buffet?
![David Schwartz headshot](/sites/default/files/styles/60_width/public/experts/highres/Schwartz_D68605_20.jpg?itok=OP_ST724)
There aren't any guidelines when it comes to passenger etiquette, but there are unwritten rules when it comes to sitting down.
![Dan Bubb Headshot Dan Bubb Headshot](/sites/default/files/styles/60_width/public/experts/highres/ED0F4B67-DCB8-4C71-8172-4FE202568493.jpeg?itok=n5ggNFcZ)
![Las Vegas Review Journal](/sites/default/files/styles/100_width_25_height/public/news_source/logo/las-vegas-review-journal.jpg?itok=IX9YBkgU)
Las Vegas Valley city courts are still reducing large numbers of speeding tickets to parking violations, a controversial practice that experts say allows dangerous drivers to put the public at risk.
![Erin Breen Headshot Erin Breen Headshot](/sites/default/files/styles/60_width/public/experts/highres/Breen_D66859_0.jpg?itok=WZ_FU5BL)
![Las Vegas Weekly](/sites/default/files/styles/100_width_25_height/public/news_source/logo/las-vegas-weekly.png?itok=ZDXAKfAu)
The world has seen what the first-of-its-kind venue Sphere can do, from the science-fiction spectacle that was the initial illumination of its LED-covered exterior in July, to this past weekend’s spectacular opening of U2’s Las Vegas concert residency
![Headshot of Marla Royne Stafford](/sites/default/files/styles/60_width/public/experts/highres/stafford_1_0.jpg?itok=yOeeh2Xx)
Top-line Phase IIa data has demonstrated an allogeneic stem-cell therapy facilitated a lack of deterioration in cognitive signals in mild Alzheimer’s.
![Headshot of Jeffrey L. Cummings](/sites/default/files/styles/60_width/public/experts/highres/JCummings_headshot_suit.jpg?itok=iQpcDnsz)
Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, today announced positive top-line results from its Phase 2a trial of its investigational product Lomecel-B™ for the treatment of mild Alzheimer’s disease.
![Headshot of Jeffrey L. Cummings](/sites/default/files/styles/60_width/public/experts/highres/JCummings_headshot_suit.jpg?itok=iQpcDnsz)
![Desert Companion](/sites/default/files/styles/100_width_25_height/public/news_source/logo/desert-companion.png?itok=jU28bvQf)
Lin ‘Spit’ Newborn and Daniel Shersty were murdered 25 years ago. Their legacies still reverberate through Las Vegas
![Headshot of Robert Futrell](/sites/default/files/styles/60_width/public/experts/highres/dl_D68857_26.jpg?itok=VTeEjzw8)